Telix Pharmaceuticals Ltd (TLX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | N/A | -29 | -272 | -125 |
| Other Investing Activity | -290 | -173 | -67 | -13 | -19 |
| Investing Cash Flow | $-290 | $-173 | $-96 | $-286 | $-144 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 282 | N/A | N/A | N/A | N/A |
| Debt Repayment | -15 | -342 | -18 | -165 | -62 |
| Common Stock Issued | 86 | N/A | 30,578 | N/A | N/A |
| Other Financing Activity | -36 | 0 | -922 | 0 | 0 |
| Financing Cash Flow | $318 | $-342 | $29,638 | $-165 | $-62 |
| Exchange Rate Effect | 2,447 | -326 | -83 | 258 | -226 |
| Beginning Cash Position | 27,506 | 38,948 | 13,133 | 12,384 | 18,214 |
| End Cash Position | 21,272 | 31,243 | 37,592 | 13,612 | 12,548 |
| Net Cash Flow | $-8,680 | $-7,380 | $24,542 | $970 | $-5,440 |
| Free Cash Flow | |||||
| Capital Expenditure | N/A | N/A | -29 | -272 | -125 |
| Free Cash Flow | 0 | 0 | -29 | -272 | -125 |